tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CVKD Stock Latest News

Cadrenal Therapeutics to initiate Phase 3 clinical trial for tecarfarin in 2025
The FlyCadrenal Therapeutics to initiate Phase 3 clinical trial for tecarfarin in 2025
1M ago
CVKD
Cadrenal Therapeutics files to sell 590K shares of common stock for holders
PremiumThe Fly
Cadrenal Therapeutics files to sell 590K shares of common stock for holders
3M ago
CVKD
Cadrenal Therapeutics target adjusted to $32 from $3 at H.C. Wainwright
PremiumThe Fly
Cadrenal Therapeutics target adjusted to $32 from $3 at H.C. Wainwright
3M ago
CVKD
Cadrenal Therapeutics Advances Tecarfarin Development
PremiumCompany Announcements
Cadrenal Therapeutics Advances Tecarfarin Development
3M ago
CVKD
Cadrenal Therapeutics Raises $5.1 Million for Tecarfarin
PremiumCompany Announcements
Cadrenal Therapeutics Raises $5.1 Million for Tecarfarin
3M ago
8K
CVKD
Cadrenal Therapeutics raises $5.1M via at-the-market facility
PremiumThe FlyCadrenal Therapeutics raises $5.1M via at-the-market facility
3M ago
CVKD
Cadrenal Therapeutics Unveils Phase 3 Trials and Market Strategy
Premium
Company Announcements
Cadrenal Therapeutics Unveils Phase 3 Trials and Market Strategy
4M ago
8K
CVKD
Cadrenal Therapeutics to discuss tecarfarin trial with FDA in September
Premium
The Fly
Cadrenal Therapeutics to discuss tecarfarin trial with FDA in September
5M ago
CVKD
Cadrenal Therapeutics Inc trading resumes
PremiumThe Fly
Cadrenal Therapeutics Inc trading resumes
6M ago
CVKD
Cadrenal Therapeutics Inc trading halted, volatility trading pause
PremiumThe Fly
Cadrenal Therapeutics Inc trading halted, volatility trading pause
6M ago
CVKD
Cadrenal Therapeutics Inc trading halted, news pending
PremiumThe Fly
Cadrenal Therapeutics Inc trading halted, news pending
6M ago
CVKD
Cadrenal Therapeutics Partners with Abbott on Cardiac Trial
PremiumCompany Announcements
Cadrenal Therapeutics Partners with Abbott on Cardiac Trial
6M ago
8K
CVKD
Cadrenal Therapeutics and Abbott partner to develop anticoagulant tecarfarin
PremiumThe FlyCadrenal Therapeutics and Abbott partner to develop anticoagulant tecarfarin
6M ago
ABT
CVKD
Cadrenal Therapeutics Enhances Incentives and Adjusts Stock Plan
Premium
Company Announcements
Cadrenal Therapeutics Enhances Incentives and Adjusts Stock Plan
6M ago
8K
CVKD
Cadrenal Therapeutics highlights data on ARIES-HM3 trial at ISHLT
Premium
The Fly
Cadrenal Therapeutics highlights data on ARIES-HM3 trial at ISHLT
8M ago
CVKD
Cadrenal Therapeutics Gains FDA Orphan Drug Status for Tecarfarin
PremiumCompany Announcements
Cadrenal Therapeutics Gains FDA Orphan Drug Status for Tecarfarin
10M ago
8K
CVKD
Cadrenal Therapeutics confirms FDA orphan designation for tecarfarin
PremiumThe Fly
Cadrenal Therapeutics confirms FDA orphan designation for tecarfarin
10M ago
CVKD
Cadrenal Therapeutics’ tecarfarin receives FDA orphan designation
PremiumThe Fly
Cadrenal Therapeutics’ tecarfarin receives FDA orphan designation
10M ago
CVKD
Cadrenal Therapeutics files $100M mixed securities shelf
PremiumThe Fly
Cadrenal Therapeutics files $100M mixed securities shelf
11M ago
CVKD
A New Cause for Concern: Cadrenal Therapeutics, Inc. Adds a New Natural and Human Disruptions Risk
PremiumCompany AnnouncementsA New Cause for Concern: Cadrenal Therapeutics, Inc. Adds a New Natural and Human Disruptions Risk
11M ago
CVKD
Cadrenal Therapeutics provides Q4 corporate update
Premium
The Fly
Cadrenal Therapeutics provides Q4 corporate update
11M ago
CVKD
Cadrenal Therapeutics Announces Key Executive Appointment
Premium
Company Announcements
Cadrenal Therapeutics Announces Key Executive Appointment
12M ago
8K
CVKD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >